Publicacións en colaboración con investigadores/as de St. Michael's Hospital (9)

2020

  1. Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium

    Frontiers in Neurology, Vol. 11

  2. Hemophagocytic syndrome following alemtuzumab treatment for multiple sclerosis: A case report

    Multiple Sclerosis and Related Disorders, Vol. 40

  3. NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430

  4. The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS

    Multiple Sclerosis Journal, Vol. 26, Núm. 13, pp. 1658-1669

2019

  1. Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis

    Neurology, Vol. 92, Núm. 13, pp. E1507-E1516

  2. Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis

    Neurology, Vol. 92, Núm. 6, pp. 296-298

2018

  1. Myasthenia gravis following alemtuzumab therapy for multiple sclerosis

    Neurology, Vol. 91, Núm. 13, pp. 622-624

  2. The value of oligoclonal bands in the multiple sclerosis diagnostic criteria

    Brain, Vol. 141, Núm. 4, pp. 1075-1084

2017

  1. Lesion topographies in multiple sclerosis diagnosis: A reappraisal

    Neurology, Vol. 89, Núm. 23, pp. 2351-2356